NovaBay Pharmaceuticals: Q4 Earnings Insights
NovaBay Pharmaceuticals: Q4 Earnings Insights
NovaBay Pharmaceuticals (AMEX:NBY) reported its Q4 earnings results on Tuesday, March 26, 2024 at 04:05 PM.
Here's what investors need to know about the announcement.
Earnings
NovaBay Pharmaceuticals beat estimated earnings by 30.0%, reporting an EPS of $-0.21 versus an estimate of $-0.3.
Revenue was up $84 thousand from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.03 which was followed by a 8.0% drop in the share price the next day.
Here's a look at NovaBay Pharmaceuticals's past performance:
| Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.40 | -0.55 | -0.91 | -0.17 |
| EPS Actual | -0.37 | -1.27 | -0.85 | -1.47 |
| Revenue Estimate | 3.55M | 3.67M | 3.20M | 5.10M |
| Revenue Actual | 3.27M | 4.61M | 3.12M | 3.64M |
To track all earnings releases for NovaBay Pharmaceuticals visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
NovaBay Pharmaceuticals (AMEX:NBY) reported its Q4 earnings results on Tuesday, March 26, 2024 at 04:05 PM.
NovaBay Pharmicals（美國證券交易所股票代碼：NBY）於2024年3月26日星期二下午4點05分公佈了其第四季度業績。
Here's what investors need to know about the announcement.
以下是投資者需要了解的有關該公告的信息。
Earnings
收益
NovaBay Pharmaceuticals beat estimated earnings by 30.0%, reporting an EPS of $-0.21 versus an estimate of $-0.3.
NovaBay Pharmicals的收益比預期高出30.0％，每股收益爲-0.21美元，而估計爲-0.3美元。
Revenue was up $84 thousand from the same period last year.
收入比去年同期增長了84,000美元。
Past Earnings Performance
過去的收益表現
Last quarter the company beat on EPS by $0.03 which was followed by a 8.0% drop in the share price the next day.
上個季度，該公司的每股收益高出0.03美元，隨後第二天股價下跌了8.0％。
Here's a look at NovaBay Pharmaceuticals's past performance:
以下是NovaBay Pharmicals過去的表現：
| Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.40 | -0.55 | -0.91 | -0.17 |
| EPS Actual | -0.37 | -1.27 | -0.85 | -1.47 |
| Revenue Estimate | 3.55M | 3.67M | 3.20M | 5.10M |
| Revenue Actual | 3.27M | 4.61M | 3.12M | 3.64M |
| 季度 | 2023 年第三季度 | 2023 年第二季度 | 2023年第一季度 | 2022 年第四季度 |
|---|---|---|---|---|
| 每股收益估算 | -0.40 | -0.55 | -0.91 | -0.17 |
| 實際每股收益 | -0.37 | -1.27 | -0.85 | -1.47 |
| 收入估算 | 3.55 米 | 3.67M | 3.20 米 | 5.10 米 |
| 實際收入 | 3.27 米 | 4.61M | 3.12 米 | 3.64 米 |
To track all earnings releases for NovaBay Pharmaceuticals visit their earnings calendar here.
要追蹤NovaBay Pharmicals發佈的所有業績，請在此處訪問其業績日曆。
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由Benzinga的自動內容引擎生成，並由編輯審閱。
譯文內容由第三人軟體翻譯。
風險及免責聲明
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能，分享給你的好友吧